Chenxi Liang1,2,3,4, Peixuan Guo1,2,3,4. 1. Center for RNA Nanobiotechnology and Nanomedicine, College of Pharmacy and College of Medicine, The Ohio State University, Columbus, Ohio 43210, United States. 2. James Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, United States. 3. Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University, Columbus, Ohio 43210, United States. 4. Biomedical Science Graduate Program, College of Medicine, The Ohio State University, Columbus, Ohio 43210, United States.
Abstract
Nanomotors in nanotechnology may be as important as cars in daily life. Biomotors are nanoscale machines ubiquitous in living systems to carry out ATP-driven activities such as walking, breathing, blinking, mitosis, replication, transcription, and trafficking. The sequential action in an asymmetrical hexamer by a revolving mechanism has been confirmed in dsDNA packaging motors of phi29, herpesviruses, bacterial dsDNA translocase FtsK, and Streptomyces TraB for conjugative dsDNA transfer. These elaborate, delicate, and exquisite ring structures have inspired scientists to design biomimetics in nanotechnology. Many multisubunit ATPase rings generate force via sequential action of multiple modules, such as the Walker A, Walker B, P-loop, arginine finger, sensors, and lid. The chemical to mechanical energy conversion usually takes place in sequential order. It is commonly believed that ATP binding triggers such conversion, but how the multimodule motor starts the sequential process has not been explicitly investigated. Identification of the starter is of great significance for biomimetic motor fabrication. Here, we report that the arginine finger is the starter of the motor. Only one amino acid residue change in the arginine finger led to the impediment and elimination of all following steps. Without the arginine finger, the motor failed to assemble, bind ATP, recruit DNA, or hydrolyze ATP and was eventually unable to package DNA. However, the loss of ATPase activity due to an inactive arginine finger can be rescued by an arginine finger from the adjacent subunit of Walker A mutant through trans-complementation. Taken together, we demonstrate that the formation of dimers triggered by the arginine finger initiates the motor action rather than the general belief of initiation by ATP binding.
Nanomotors in nanotechnology may be as important as cars in daily life. Biomotors are nanoscale machines ubiquitous in living systems to carry out ATP-driven activities such as walking, breathing, blinking, mitosis, replication, transcription, and trafficking. The sequential action in an asymmetrical hexamer by a revolving mechanism has been confirmed in dsDNA packaging motors of phi29, herpesviruses, bacterial dsDNA translocase FtsK, and Streptomyces TraB for conjugative dsDNA transfer. These elaborate, delicate, and exquisite ring structures have inspired scientists to design biomimetics in nanotechnology. Many multisubunit ATPase rings generate force via sequential action of multiple modules, such as the Walker A, Walker B, P-loop, arginine finger, sensors, and lid. The chemical to mechanical energy conversion usually takes place in sequential order. It is commonly believed that ATP binding triggers such conversion, but how the multimodule motor starts the sequential process has not been explicitly investigated. Identification of the starter is of great significance for biomimetic motor fabrication. Here, we report that the arginine finger is the starter of the motor. Only one amino acid residue change in the arginine finger led to the impediment and elimination of all following steps. Without the arginine finger, the motor failed to assemble, bind ATP, recruit DNA, or hydrolyze ATP and was eventually unable to package DNA. However, the loss of ATPase activity due to an inactive arginine finger can be rescued by an arginine finger from the adjacent subunit of Walker A mutant through trans-complementation. Taken together, we demonstrate that the formation of dimers triggered by the arginine finger initiates the motor action rather than the general belief of initiation by ATP binding.
Biological motors, or biomotors in short,
are nanoscale machines
ubiquitous in many biological processes in both prokaryotes and eukaryotes,[1−3] such as cell mitosis, DNA replication,[4,5] RNA transcription,[6] macromolecule trafficking,[7] and viral genome packaging.[8−14] Understanding the mechanism of biomotor function is essential for
the studies on biological systems and for the development of new targeting
drugs against bacterial or viral infections. One important component
of motors is the ATPase, which belongs to one class of enzymes that
catalyze the decomposition of adenosine triphosphate (ATP) into adenosine
diphosphate (ADP) and a free phosphate ion. They serve as the main
energy source for the mechanical work of biomotors, just like the
engine for a car. For ring-shaped ATPases found in biomotors, conversion
from chemical to mechanical energy usually takes place in a sequential
manner among the subunits, coupled with conformational changes of
the oligomer. While it is commonly believed that ATP binding triggers
such conversion, how ATPases start the sequential process has not
been explicitly investigated. The arginine finger (R-finger), Walker
A (WA), and Walker B (WB) residues are three commonly conserved motifs
in ATPases responsible for ATP binding and hydrolysis.[15−18] For ring-shaped ATPases such as the AAA+ family, R-fingers are found
at the intersubunit interface regulating ATPase activities.[19,20] For instance, various mutants were assayed for ATPase activity and
the trans-acting Arg139 was identified to be the R-finger of TerL
ATPase.[21]The dsDNA packaging motor
of bacteriophage phi29 has long been
used as a model to study the viral DNA packaging pathway for a long
time. In this motor, dsDNA is pushed through a one-way valve; an asymmetrical
hexameric ring and a dodecameric connector channel follow a revolving
mechanism (Figure ).[22−25] This revolving mechanism is common among different species of dsDNA
translocases. The use of an arginine finger to control the sequential
action[26,27] through the asymmetrical hexamer of the
revolving motor has been confirmed in different kinds of dsDNA translocating
or packaging motors, such as the DNA packaging motor of phi29,[28] herpesviruses,[29,30] the DNA translocase
FtsK of Gram-negative bacteria,[31] and the
TraB in Streptomyces for conjugative plasmid DNA transfer.[32−34]
Figure 1
illustration
of the Phi29 DNA packaging motor. The motor mainly
consists of three coaxial parts: the connector (portal protein), the
pRNA hexameric ring, and the ATPase gp16. Gp16 are assembled into
the motor complex bridged by pRNA. (A) The revolving mechanism of
the motor ATPase gp16 to translocate dsDNA. (B) Side view of the phi29
packaging motor. (C) Top view (right) and bottom view (left) of the
motor complex showing the hexameric pRNA ring and the connector channel.
illustration
of the Phi29 DNA packaging motor. The motor mainly
consists of three coaxial parts: the connector (portal protein), the
pRNA hexameric ring, and the ATPase gp16. Gp16 are assembled into
the motor complex bridged by pRNA. (A) The revolving mechanism of
the motor ATPase gp16 to translocate dsDNA. (B) Side view of the phi29
packaging motor. (C) Top view (right) and bottom view (left) of the
motor complex showing the hexameric pRNA ring and the connector channel.The gene product 16 (gp16) of bacteriophage phi29
has long been
employed to study the sequential process in ring-shaped ATPases (Figure ).[28,35,36] Based on the sequence and structural analysis,
the R-finger of gp16 was determined to be Arg146, after the α4
helix. WA and WB residues are also located near the R-finger with
a sequence of GXXGXGKS/T8 and hhhhDE, respectively. To
translocate the viral genome double-stranded DNA (dsDNA) into the
preformed capsid, the multimeric gp16 ATPases have to undergo concerted
steps: ATP binding, substrate binding, ATP hydrolysis, and finally
conformational changes leading to movement of the substrate. Even
without knowing the exact sequence of these steps, we can reasonably
assume that the halt of the very initial step will impair all the
subsequent functional steps.Through biochemical assays, we
have shown that the R-finger of
gp16 is indispensable for subunit dimerization, ATP binding, DNA binding,
and viral assembly. Together with molecular modeling and simulations,
we illustrated how the structural motifs of gp16 mediate the subunit–subunit
interaction in a trans-acting manner. It has also been found that
gp16 without an active R-finger can rescue ATP hydrolysis activity
of an inactive Walker A mutant by trans-complementation. Therefore,
we suggest that the R-finger of gp16 facilitates the dimerization
of two adjacent subunits and initiates the sequential energy conversion
process, finally leading to DNA translocation. We also anticipate
such a structural initiation mechanism to be conserved among the ring-shaped
ATPase family. Identification of this motor initiation mechanism will
also benefit the assembly of artificial biomotors in vitro and our understanding of the complex mechanism behind biopolymer
translocation.
Results and Discussion
Indispensability of Arginine
Finger for gp16
Dimerization
The formation of gp16 dimers in the absence
of ATP has been reported extensively as tracking back to 1986.[37] When the phi29 gp16 gene was engineered and
expressed in E. coli, gp16 was found to form oligomers.
The wild-type gp16 conjugated with enhanced Green Fluorescent Protein
(eGFP) can form dimers, trimers, and other oligomers through Native-PAGE
without ATP.[38] At least six different bands
indicate that different states of oligomers exist in the solution.However, the oligomer formation was impaired by the reengineering
of R146 of the gp16, which is shown to be the R-finger of gp16.[20,39] The ultracentrifugation of the engineered R-finger mutant showed
only one peak representing monomer gp16 mutants in the 15%–35%
glycerol gradient compared to other reengineered gp16 with two peaks
representing monomers and dimers. Interestingly, the reengineered
R-finger shows intersubunit interaction between wild-type gp16 and
other mutants, i.e., the reengineered Walker A mutant
and Walker B mutant.[40] These results demonstrate
that the R-finger is indispensable for dimer formation of gp16. Given
that dimer can be formed without ATP, it is possible for dimerization
to precede ATP binding and hydrolysis.However, the renatured
gp16 monomer lost the biological activity
within 40 min in solution due to protein/protein interaction.[37] Although dimer formation is the key to gp16
function, adding gp16 monomer is required for gp16 to work in the
motor since each motor contains only one dimer and four monomers at
any transient movement.[41] In other words,
gp16 dimer is the initiation step via the contact
of the arginine finger with the P loop of Walker A to form an ATP
binding pocket (see below). The dimer is subsequently stabilized by
the binding of ATP (or γ-S-ATP). Thus, the purified gp16 dimer
alone could not have DNA packaging activity.[20] When acetone and PEG were added to the gp16 solution to interfere
with the dimer formation, the gp16 showed a significant increase of
activity and displayed a much longer shelf life.[42]
Indispensability of Arginine Finger for ATP
Binding
A re-engineered R-finger mutant R146A was investigated.
In this mutant the 146th arginine was replaced by alanine.[20,39] The ATP binding affinity of this R-finger mutant, R146A, was evaluated
through native PAGE together with the re-engineered Walker B mutant
118/9 DE, in which the 118th aspartic acid and 119th glutamic acid
were reversed. Radioactively labeled 32P-ATP was used to
determine if the mutant gp16 binds ATP (Figure ). Surprisingly, the R146A showed no affinity
for 32P-ATP in either the presence or absence of γ-S-ATP
(Figure A), indicating
that the re-engineered R146A mutation compromised its ATP binding
ability.
Figure 2
Indispensability of arginine finger for ATP binding. Phosphate
imaging of 32P-ATP and different gp16-eGFP mutants. The
arginine mutant R146A loses the ATP binding ability completely. The
WT, Walker B motif (118/9DE), and arginine finger mutant (R146A) were
incubated with 40bp DNA, pRNA, and 10 μM 32P-ATP
with (+) and w/o (−) γ-S-ATP. “0” is the
negative control without gp16. (A) Phosphate imaging overnight showing
signal of 32P-ATP. (B) eGFP channel showing the signal
of gp16-eGFP.
Indispensability of arginine finger for ATP binding. Phosphate
imaging of 32P-ATP and different gp16-eGFP mutants. The
arginine mutant R146A loses the ATP binding ability completely. The
WT, Walker B motif (118/9DE), and arginine finger mutant (R146A) were
incubated with 40bp DNA, pRNA, and 10 μM 32P-ATP
with (+) and w/o (−) γ-S-ATP. “0” is the
negative control without gp16. (A) Phosphate imaging overnight showing
signal of 32P-ATP. (B) eGFP channel showing the signal
of gp16-eGFP.
Indispensability of Arginine
Finger for DNA
Binding
The ATPase gp16 undergoes a conformational change
after binding to ATP, leading to a higher affinity for DNA molecules.
In a full function cycle of the motor, the bound ATP is subsequently
hydrolyzed, a reaction that is required for the translocation of dsDNA.
The nonhydrolyzed γ-S-ATP can be used to block the ATP binding/hydrolysis
cycle and “freeze” the gp16 in a conformation that favors
DNA binding. A mutation in R-finger also impaired the DNA binding
ability of gp16.EMSA was used to show that R146A lost its affinity
for DNA completely (Figure ). After the DNA was incubated with γ-S-ATP and wild-type
gp16-eGFP, an upshift of the fluorescent DNA band was observed. Adding
more wild-type gp16-eGFP resulted in a complete upshift of the fluorescent
DNA band, while adding mutant without arginine finger did not lead
to an upshift of the fluorescent DNA band, regardless of the amount
added. It was rationalized that the lack of DNA binding in WA-RF mutant
gp16 is a consequence of its inability to bind ATP due to arginine
mutation.
Figure 3
Indispensability of arginine finger for DNA binding. The interaction
of DNA labeled with Alexa647 with either the WT gp16 or the Walker
A–arginine finger double mutant gp16 (WA-RF gp16) were tested
by electrophoretic mobility shift assay (EMSA). When increasing the
amount of WT gp16, more DNA bound to the WT gp16 protein (lane 2–7),
while the Walker A–arginine finger mutant did not show binding
to DNA (lanes 8–13). (A) eGFP channel showing the signal of
gp16-eGFP. (B) Alexa647 channel showing the signal of red fluorescent-DNA.
(C) Overlap image (merged) of A and B.
Indispensability of arginine finger for DNA binding. The interaction
of DNA labeled with Alexa647 with either the WT gp16 or the Walker
A–arginine finger double mutant gp16 (WA-RF gp16) were tested
by electrophoretic mobility shift assay (EMSA). When increasing the
amount of WT gp16, more DNA bound to the WT gp16 protein (lane 2–7),
while the Walker A–arginine finger mutant did not show binding
to DNA (lanes 8–13). (A) eGFP channel showing the signal of
gp16-eGFP. (B) Alexa647 channel showing the signal of red fluorescent-DNA.
(C) Overlap image (merged) of A and B.
Indispensability of Arginine Finger for ATP
Hydrolysis
It was shown that R146A impaired the ATP hydrolysis
function of gp16 compared to wildtype (Figure ). From a structural perspective, the R146A
mutation could not alter either the WB motif, which is essential for
ATP hydrolysis, or the WA motif, which is essential for ATP binding.
Therefore, it is concluded that besides the Walker motifs, the R-finger
is also essential for ATP binding and hydrolysis.
Figure 4
Indispensability of arginine
finger for ATP hydrolysis. The ATPase
activities of WT gp16 and its mutants Walker A (G27D), Walker B (E119A),
and arginine finger (R146A) were measured by fluorometry. The fluorescent
signals which represent the ATPase activity were measured every 30
min after mixing. The results were normalized to the ATPase activity
of WT gp16 after 120 min.
Indispensability of arginine
finger for ATP hydrolysis. The ATPase
activities of WT gp16 and its mutants Walker A (G27D), Walker B (E119A),
and arginine finger (R146A) were measured by fluorometry. The fluorescent
signals which represent the ATPase activity were measured every 30
min after mixing. The results were normalized to the ATPase activity
of WT gp16 after 120 min.
Indispensability of Arginine Finger for DNA
Packaging
The DNA packaging ability of the R146A was tested
(Figure ). The band
of the packaged DNA can be seen using the wild-type gp16. However,
the band of packaged DNA is almost invisible when the R146A mutant
was added to the solution equivalent to 75% of the wild type gp16.
Even 25% of R146A mutant had a negative effect on the packaging process,
compared to the addition of the buffer (Figure ). Apparently, R146A does not have the assembly
ability since it loses its function in ATP binding, ATP hydrolysis,
and DNA binding. However, this result indicates that R146A can still
interact with the wild-type gp16, thus blocking the function of the
wild-type gp16. Given that the R146A mutant also affects the dimerization
of gp16, it is reasonable to assume that the wild-type gp16 can use
its own R-finger to bind R146A, but the R146A in the dimer cannot
bind to the next gp16, so that the packaging process is blocked.
Figure 5
Indispensability
of arginine finger for DNA packaging. The arginine
finger mutant (R146A) was biologically inactive in DNA packaging as
demonstrated by its inhibition to DNA packaging activity of WT gp16.
An in vitro DNA packaging assay was carried out using
a series of titrations of WT gp16 with buffer, Walker B mutant E119A,
and arginine finger mutant R146A. (A) EtBr staining of the agarose
gel showing the packaged DNA (black arrow). R146A gp16 by itself did
not have DNA packaging activity. (B) Bar chart of the grayscale measurement
of the packaged DNA. Data were normalized to the activity of only
WT gp16.
Indispensability
of arginine finger for DNA packaging. The arginine
finger mutant (R146A) was biologically inactive in DNA packaging as
demonstrated by its inhibition to DNA packaging activity of WT gp16.
An in vitro DNA packaging assay was carried out using
a series of titrations of WT gp16 with buffer, Walker B mutant E119A,
and arginine finger mutant R146A. (A) EtBr staining of the agarose
gel showing the packaged DNA (black arrow). R146A gp16 by itself did
not have DNA packaging activity. (B) Bar chart of the grayscale measurement
of the packaged DNA. Data were normalized to the activity of only
WT gp16.
Arginine Finger Mutant
to Rescue the ATP Hydrolysis
Activity of Walker A Mutant by Trans-Complementation
On the
basis of previous results, R146A loses all ATPase functions. However,
the R-finger was found not directly involved in ATP binding and hydrolysis
but instead to facilitate the dimerization of gp16. Hence, based on
the structure of gp16 (Figure ), the dimerization of gp16 should also be essential for ATPase
function, and the lost function could be recovered through mixing
R146A with a gp16 mutant with the intact R-finger. This hypothesis
was tested by assessing the ATPase activity of a combination of different
gp16 mutants. For example, the Walker A mutant G27D, in which the
27th glycine was replaced by aspartic acid, and the arginine finger
mutant R146A (Figure A) were used for the assay. When R146A was mixed with G27D in different
ratios, an ATP activity curve was observed representing a complementary
effect (Figure A,B).
When R146A was mixed with G27D in a 1:1 ratio, the highest ATPase
activity was observed (Figure A,B). This indicates a complementary effect between R146A
and G27D. We further showed that this complementary effect was not
affected by the introduction of DNA or γ-S-ATP (Figure B). On the other hand, mixing
E119A, in which the Walker B motif was mutated, with G27D in different
ratios did not display the complementation effect, since in both Walker
A and Walker B mutants the ATPase function was inactivated. Then a
transaction will not rescue the ATPase activity. The result suggests
that the arginine finger of gp16 can interact with another gp16 subunit,
functioning as an ATPase dimer in a transacting manner (Figure A).
Figure 6
Crystal structure of
the N terminus of gp16 (top figure, PDB file: 5HD9) and the location
of the mutations (bottom table). The red amino acids in the table
indicate the mutation sites.
Figure 7
Fluorometry
to study the complementary effect of ATP hydrolysis
ability among different gp16 mutants. The fluorescent signals were
measured every 30 min after mixing, and the data were normalized to
the activity of WT gp16 after 120 min. (A) Test of the complementary
effect of gp16 mutants: Walker A mutant (G27D) complement with Walker
B mutant (E119A), and Walker A mutant (G27D) complement with Arginine
mutant R146A. (B) Complementary effect of G27D and R146A w/or w/o
DNA and γ-S-ATP (n = 2). (C) Complementary
effect of another Walker A mutant K30/S31A and R146A (n = 2).
Crystal structure of
the N terminus of gp16 (top figure, PDB file: 5HD9) and the location
of the mutations (bottom table). The red amino acids in the table
indicate the mutation sites.Fluorometry
to study the complementary effect of ATP hydrolysis
ability among different gp16 mutants. The fluorescent signals were
measured every 30 min after mixing, and the data were normalized to
the activity of WT gp16 after 120 min. (A) Test of the complementary
effect of gp16 mutants: Walker A mutant (G27D) complement with Walker
B mutant (E119A), and Walker A mutant (G27D) complement with Arginine
mutant R146A. (B) Complementary effect of G27D and R146A w/or w/o
DNA and γ-S-ATP (n = 2). (C) Complementary
effect of another Walker A mutant K30/S31A and R146A (n = 2).To further prove the complementary
idea, a two-point mutation of
the Walker A motif was introduced to generate the K30/S31A mutant
(Figure C). This mutant
replaced the 30th lysine and 31st serine with alanine. As expected,
the K30/S31A also has a complementary effect with R146A. In addition,
when mixing these two mutants together, the ATPase activity of gp16
mutants was significantly recovered to about 40% of the wild-type
gp16. The results indicate that the gp16 functions as an ATPase in
a dimeric form, and the ATP hydrolysis function was carried out by
two gp16 subunits to work together.
Conclusion
We
demonstrated that the arginine finger of gp16 is necessary for
its ATPase function and DNA binding. Single-point mutation of the
arginine finger in gp16 lost the ability of subunit dimerization,
ATP binding, DNA binding, ATP hydrolysis, and DNA packaging. However,
the loss of ATPase function can be rescued by the complementary effect
of Walker A mutant G27D and K30/S31A. Since the arginine finger directly
affects subunit dimerization, the fact that arginine finger mutation
impairs the ATPase function and DNA binding indicates that the dimerization
of gp16 is the prerequisite of all subsequent steps for a functioning
gp16 ATPase ring. If, under natural conditions, the ATP binding and
hydrolysis steps happen before the dimerization, these processes would
not need an intact arginine finger to proceed. As a result, we conclude
that the dimerization of gp16 through the R-finger is the initial
step of the sequential process leading to DNA packaging in the bacteriophage
phi29 motor.
Experimental Methods
Engineering,
Fabrication, And Purification
of Motor Components
The engineering and purification of the
eGFP-gp16 protein have been reported previously.[43] The design of gp16 mutants is shown in Figure . The eGFP-gp16 arginine finger
mutant (R146A), eGFP-gp16 Walker A mutant (G27D, K30/S31A), gp16 Walker
B mutant (118/9 ED, E119A), and eGFP-gp16 mutant R146A were fabricated
by engineering the gp16 gene (Keyclone Technologies). Briefly, the
protein was overexpressed in E. coli BL21(DE3) with
induction of 0.4 mM IPTG. The bacterial cells were harvested and resuspended
in His-binding buffer (20 mM Tris–HCl, pH 7.9, 500 mM NaCl,
15% glycerol, 0.5 mM TCEP and 0.1% Tween-20). The cells were then
lysed by passing through a French press, and the lysate was clarified
by centrifugation. 0.1% PEI was added to the clarified lysate to remove
nucleotides and other proteins. Homogeneous eGFP-gp16 was purified
by one-step Ni-resin chromatography.
Native PAGE and Phosphate
Imaging
Wild-type and mutant gp16-eGFP were mixed with 0.05
μM DNA,
0.5 ng/μL pRNA, and 10 μM 32P-ATP. A final
concentration of 1 mM γ-S-ATP was introduced if needed. After
incubation at room temperature for 30 min, all of the samples were
loaded to a 4–15% acrylamide gel (Tris, glycine) and run for
90 min under 90 V. After the gel was exposed for eGFP signal, the
gel was dried and then exposed for phosphate imaging overnight.
Electrophoretic Mobility Shift Assay (EMSA)
A fluorescently
tagged protein that facilitates detection and purification
was shown to possess similar assembly and packaging activity as compared
to wild type.[27,43] The EMSA method has been described
previously.[38,44] Wild-type and mutant gp16 proteins
were mixed with a 50bp DNA conjugated with Alexa647 in the presence
of γ-S-ATP with a final concentration of 0.5 μM. Samples
were incubated at room temperature for 20 min and then loaded onto
a 1% agarose gel (44.5 mM Tris, 44.5 mM boric acid) and electrophoresed
at 4 °C for around 1 h at 8 V/cm. The fluorescent signals of
gp16 and DNA-Alexa647 were analyzed using a Typhoon FLA 7000 laser
scanner.
Measurement of ATPase Activity by Fluorometry
A malachite
Green Phosphate Assay Kit (Cayman Chemical) was used
to examine the ATPase activity of gp16 in the presence or absence
of the 33bp dsDNA and γ-S-ATP that was described previously.
Purified gp16 was mixed with a final concentration of 1 ng/μL
pRNA, MDCC-PBP containing 0.2 U/mL of purine nucleoside phosphorylase
(PNPase), 0.04 mM 7-methyl guanosine, and 6% glycerol. The DNA and
γ-S-ATP were added based on the experimental design with a final
concentration of 0.1 and 0.2 μM, separately. Then a final concentration
of 1 μM ATP was added. After addition of ATP to start the ATP
hydrolysis, ATPase gp16 generated Pi that was scavenged
by MDCC-. The Pi-bound MDCC-PBP released a fluorescent
signal in 464 nm when excited at 425 nm. The fluorescent signals were
measured by BioTek Synergy 4 plate reader.
DNA Packaging Assay
DNA packaging
assay has been previously described.[45] In
short, the viral prohead-connector complex, pRNA, gp16, and phi29
DNA-gp3 complex were mixed together. DNase was used to remove the
unpackaged DNA, and after that procapsid was digested with proteinase
K to release the packaged DNA. The packaged DNA was observed through
a 1% agarose gel in TAE buffer. The wild-type gp16 was diluted with
either a titration of R146A gp16 mutant or gp16 solution buffer as
the control.
Authors: Brendan J Hilbert; Janelle A Hayes; Nicholas P Stone; Caroline M Duffy; Banumathi Sankaran; Brian A Kelch Journal: Proc Natl Acad Sci U S A Date: 2015-07-06 Impact factor: 11.205
Authors: Andrey A Lebedev; Margret H Krause; Anabela L Isidro; Alexei A Vagin; Elena V Orlova; Joanne Turner; Eleanor J Dodson; Paulo Tavares; Alfred A Antson Journal: EMBO J Date: 2007-03-15 Impact factor: 11.598